ELITE PHARMACEUTICALS INC /NV/ (OTC:ELTP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 17, 2026.
The Healthcare company reported Q0 revenue of .
ELITE PHARMACEUTICALS INC /NV/'s stock currently trades at $0.45 with a market capitalization of $554.5M.